For example, pH-responsive Janus MNMs can maintain structural stability in gastric acid, and upon reaching the intestine, trigger the release of loaded anti-inflammatory drugs via pH stimulation, reducing the colonic inflammation score by over 60% in ulcerative colitis (UC) model mice [33]
Report any suspected side effects to the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk
At JumpstartMD, every Support Pack is carefully designed to address real, common health goalslike improving metabolism, enhancing energy, supporting gut health, or balancing hormones
Will an oral PCSK9 inhibitor improve patient adherence and change the lipid management landscape
A body-recomposition-focused plan may include: This is where future medications like retatrutide may become part of a more sophisticated model of care
Diagnosis of hyperandrogenism: biochemical criteria